Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Jairo Sebastián Astudillo VallejoFabio Lopes DE QueirozAntônio Lacerda FilhoPaulo Rocha França NetoBreno Xaia Martins DA CostaRodrigo Almeida PaivaSilvério Leonardo Macedo GarciaSergio Botrel SilvaPublished in: Revista do Colegio Brasileiro de Cirurgioes (2023)
CRS with HIPEC is an option for pacients with primary or secondary PC. Although complication rates are high, a longer survival rate may be attained compared to those seen in previously published results; in some cases, patients may even be cured.
Keyphrases